Purchase Order 75D30123P17278
- Not listed
- The Centers for Disease Control and Prevention, specifically its Pittsburgh division, awarded a $59.2K firm fixed-price purchase order to Quanterix Corporation on December 19, 2024, for maintenance services on the Quanterix SP-X system. The contract, which carries no set-aside designation, extends through December 18, 2029, and will be performed in Atlanta, Georgia. Quanterix Corporation, headquartered in Billerica, Massachusetts, is a life sciences company specializing in ultra-sensitive...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
- This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
- This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Quanterix Corporation for a Quanterix SR-X Ultra-Sensitive Biomarker Detection System and related equipment and services. The total ceiling value of the contract is $89,500.00. This award is not associated with a set-aside program. Quanterix Corporation is a life sciences company that specializes in ultra-sensitive...
- The Department of Health and Human Services, National Institutes of Health awarded a firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer of goods, for the N4PA SIMOA 2.0 ASSAY KIT. The $112,969.08 award, with an October 2020 completion date, was not set aside. Quanterix has received over $30 million in prior federal contracts from agencies like the NIH, Department of Veterans Affairs, and Department of Defense to supply its ultra-sensitive digital biomarker...
- This is a firm-fixed-price purchase order awarded by the National Institute of Nursing Research (NINR), a civilian agency, to Quanterix Corporation, a for-profit manufacturer of advanced biomedical equipment and research services. The $24,416.10 contract is for the supply of Quanterix's Simoa HD-X Analyzer, SR-X Biomarker Detection System, and related maintenance services. Quanterix is the prime contractor, and there are no set-aside designations mentioned. The contract award is not associated...
- This firm-fixed-price purchase order was awarded by the National Institute of Nursing Research (NINR), a civilian agency under the National Institutes of Health (NIH), to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $3,070.94 contract is for the procurement of Quanterix's Simoa (single molecule array) biomarker detection equipment and related maintenance services. Quanterix has received multiple federal contract awards...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract, valued at $83,468.01, is for rat biomarker analysis services in support of the U.S. Army Research Institute of Environmental Medicine (USARIEM). The contract has an ultimate completion date of January 6, 2025. The original solicitation did not use a set-aside...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Quanterix Corporation. The contract, valued at $135,937.50, is for the provision of the Quanterix ELISA (Enzyme-Linked Immunosorbent Assay) System, which is used for ultra-sensitive digital biomarker detection. This contract was set aside for small businesses. Quanterix Corporation is a life sciences company specializing in advanced...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention's (CDC) Pittsburgh office to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $160,091.47 contract is for the identification of biomarkers for occult diseases, with a completion date of October 27, 2023. Quanterix, the prime contractor, provides advanced instruments, assay kits, and research services to federal government agencies to support biomedical research and diagnostic development. The contract was awarded without a set-aside designation, reflecting Quanterix's specialized capabilities in the field of biomarker detection. Quanterix has previously delivered similar products and services to various federal agencies, including the National Institutes of Health (NIH), Department of Veterans Affairs (VA), and Department of Defense (DoD), supporting research in areas such as neurology, infectious diseases, and cancer.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $160.1k | 9/27/23 |